Drug Trial Radar · NCT00980980
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
Last checked: Nov 19, 2026Latest source record: May 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74,256
Actual
Start
Sep 2009
Primary completion
Sep 2011
Study completion Sep 2011
Sponsor
- Lead sponsor
- Harvard Pilgrim Health CareAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Agency for Healthcare Research and Quality (AHRQ); Centers for Disease Control and Prevention; Hospital Corporation of America; University of California, Irvine; Department of Population Medicine, Harvard Medical School / Harvard Pilgrim Healthcare Institute
- First posted
- Sep 21, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Primary purpose
- Prevention
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Randomized Evaluation of Decolonization versus Universal Clearance to Eliminate MRSA (REDUCE MRSA) Trial is a cluster randomized trial of the comparative effectiveness of three strategies to prevent methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units. The three strategies to be evaluated are: * screening on admission followed by isolation of MRSA+ patients * screening on admission followed by isolation and decolonization of MRSA+ patients * universal decolonization on admission with no screening. The decolonization regimen involves bathing with chlorhexidine plus intra-nasal application of mupirocin. The main outcome will be MRSA+ clinical cultures. The study is a partnership between the CDC, the CDC Prevention Epicenters, and the Hospital Corporation of America.
Conditions
- Methicillin-resistant Staphylococcus Aureus
Interventions
Chlorhexidine bath and nasal mupirocinDrug
The intervention / decolonization regimen will consist of the most commonly used topical regimen in the US - a combination of daily baths with 2% chlorhexidine cloths , plus 5 days of topical intranasal mupirocin ointment (bilateral nares, twice daily)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Main Outcome: Patients With Nosocomial MRSA Clinical CulturesTime frame: The 30-month time frame represents 12-month baseline and 18-month intervention periods. During these time periods, outcomes are defined as events occurring during attributed ICU time: from day 3 of the ICU stay until 2 days after ICU discharge.
Locations
42 sites in 1 country. Site status is shown where the registry gives one.
Alaska Regional
Anchorage, Alaska
Los Robles Hosp & Med Ctr
Thousand Oaks, California
The Medical Center of Aurora
Aurora, Colorado
Blake Medical Center
Brandenton, Florida
Brandon Hospital
Brandon, Florida
Columbia Hosp Corp S Broward (Westside)
Fort Lauderdale, Florida
Palms West Hospital
Fort Lauderdale, Florida
Plantation General
Fort Lauderdale, Florida
Regional Med Cr Bayonet Point
Hudson, Florida
Largo Medical Center
Largo, Florida
Community Hospital
New Port Richey, Florida
Orange Park Med Ctr
Orange Park, Florida
Fawcett Memorial Hospital
Port Charlotte, Florida
Doctors Hospital of Sarasota
Sarasota, Florida
South Bay Hospital
Sun City Center, Florida
Capital Regional Med Ctr
Tallahassee, Florida
Coliseum (Macon) Northside
Macon, Georgia
Coliseum Medical Center
Macon, Georgia
Cartersville Medical Center
Tucker, Georgia
Eastern Idaho Reg Med Ctr
Idaho Falls, Idaho
Garden Park Medical Center
Gulfport, Mississippi
Lee's Summit Medical Center
Kansas City, Missouri
Menorah Medical Center
Kansas City, Missouri
Overland Park Regional Hospital
Kansas City, Missouri
Research Belton Hospital
Kansas City, Missouri
Moutainview Medical Center
Las Vegas, Nevada
Parkland Medical Center
Derry, New Hampshire
Oklahoma University Medical Center
Oklahoma City, Oklahoma
Grand Strand Regional Medical Center
Myrtle Beach, South Carolina
Parkridge Medical Center
Chattanooga, Tennessee
Centennial Medical Center
Nashville, Tennessee
Stonecrest
Smyrna, Tennessee
St. David's Medical Center
Austin, Texas
Del Sol Medical Center
El Paso, Texas
Las Palmas Medical Center
El Paso, Texas
Medical Center of Plano
Plano, Texas
Methodist Hospital
San Antonio, Texas
Clear Lake Regional
Webster, Texas
Montgomery Regional Hospital
Blacksburg, Virginia
Columbia Alleghany Regional Hospital
Low Moor, Virginia
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.